These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8374048)

  • 21. Acetylcholinesterase prophylaxis against organophosphate toxicity.
    Wolfe AD; Rush RS; Doctor BP; Koplovitz I; Jones D
    Fundam Appl Toxicol; 1987 Aug; 9(2):266-70. PubMed ID: 3653568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approaches to protection against nerve agent poisoning. (Naphthylvinyl)pyridine derivatives as potential antidotes.
    Gray AP; Platz RD; Henderson TR; Chang TC; Takahashi K; Dretchen KL
    J Med Chem; 1988 Apr; 31(4):807-14. PubMed ID: 3351860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel carbamate derivatives as selective butyrylcholinesterase inhibitors.
    Bajda M; Łątka K; Hebda M; Jończyk J; Malawska B
    Bioorg Chem; 2018 Aug; 78():29-38. PubMed ID: 29529519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and structure-activity relationships of antidotes to organophosphorus anticholinesterase agents.
    Gray AP
    Drug Metab Rev; 1984; 15(3):557-89. PubMed ID: 6386410
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of parasympatholytics on the therapeutic effectiveness of the oxime HI-6 against organophosphorus compounds (Soman, substance VX, Fosdrin) in mice].
    Kassa J; Vachek J
    Cas Lek Cesk; 1997 Feb; 136(4):124-6. PubMed ID: 9221183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soman and receptor-ligand interaction in Electrophorus electroplaques.
    Bullock JO; Farquharson DA; Hoskin FC
    Biochem Pharmacol; 1977 Feb; 26(4):337-43. PubMed ID: 849325
    [No Abstract]   [Full Text] [Related]  

  • 27. Protection against both lethal and behavioral effects of soman.
    Harris LW; McDonough JH; Stitcher DL; Lennox WJ
    Drug Chem Toxicol; 1984; 7(6):605-24. PubMed ID: 6534735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reversible inhibition of acetylcholinesterases of different origins by quaternary phosphonium compounds].
    Brestkin AP; Brovko VS; Zhukovskiĭ IuG; Kolchanova NA; Mirzabaev EA
    Zh Evol Biokhim Fiziol; 1986; 22(2):123-6. PubMed ID: 3716682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of cholinolytic drug selection for the efficacy of HI-6 against soman in rats.
    Kassa J
    Toxicology; 1997 Jan; 116(1-3):147-52. PubMed ID: 9020515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the efficacy of newly developed reversible inhibitors of acetylcholinesterase with commonly used pyridostigmine as pharmacological pre-treatment of soman-poisoned mice.
    Kassa J; Musilek K; Koomlova M; Bajgar J
    Basic Clin Pharmacol Toxicol; 2012 Apr; 110(4):322-6. PubMed ID: 21981462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 3. Synthesis and evaluation of (alkenyloxy)-, (alkynyloxy)-, and (aralkyloxy)methyl quaternarized 2-[(hydroxyimino)methyl]-1-alkylimidazolium halides as reactivators and therapy for soman intoxication.
    Bedford CD; Harris RN; Howd RA; Goff DA; Koolpe GA; Petesch M; Koplovitz I; Sultan WE; Musallam HA
    J Med Chem; 1989 Feb; 32(2):504-16. PubMed ID: 2913311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereospecific reactivation by some Hagedorn-oximes of acetylcholinesterases from various species including man, inhibited by soman.
    de Jong LP; Wolring GZ
    Biochem Pharmacol; 1984 Apr; 33(7):1119-25. PubMed ID: 6712722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone- and dose schedule-dependent protection by HI-6 against soman and tabun poisoning.
    Lundy PM; Goulet JC; Hand BT
    Fundam Appl Toxicol; 1989 Apr; 12(3):595-603. PubMed ID: 2659414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase.
    Maxwell DM; Brecht KM; Doctor BP; Wolfe AD
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1085-9. PubMed ID: 8450452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
    Maxwell DM; Koplovitz I
    J Pharmacol Exp Ther; 1990 Aug; 254(2):440-4. PubMed ID: 2384881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organophosphate-induced convulsions and prevention of neuropathological damages.
    Tuovinen K
    Toxicology; 2004 Mar; 196(1-2):31-9. PubMed ID: 15036754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evaluation of prophylactic efficacy of newly developed reversible inhibitors of acetylcholinesterase in soman-poisoned mice - a comparison with commonly used pyridostigmine.
    Kassa J; Korabecny J; Sepsova V; Tumova M
    Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):571-6. PubMed ID: 24842281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and structure-activity relationships of open D-Ring galanthamine analogues.
    Herlem D; Martin MT; Thal C; Guillou C
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2389-91. PubMed ID: 12824041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidotal efficacy of pyridinium chloride derivatives against soman poisoning.
    Vrdoljak AL; Lovrić J; Radić B; Zlender V
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):17-21. PubMed ID: 16867165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization and in vitro evaluation of substituted N-(2-phenylcyclopropyl)carbamates as acetyl- and butyrylcholinesterase inhibitors.
    Horáková E; Drabina P; Brož B; Štěpánková Š; Vorčáková K; Královec K; Havelek R; Sedlák M
    J Enzyme Inhib Med Chem; 2016; 31(sup3):173-179. PubMed ID: 27476673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.